Farms.com Home   Ag Industry News

How bumblebees pollinate can change with neonic exposure: U of G research

Neonics can alter how bumblebees receive information

By Diego Flammini
Assistant Editor, North American Content
Farms.com

According to new research from the University of Guelph, neonicotinoid pesticides can change the way bumblebees collect pollen.

The study, Chronic exposure to a neonicotinoid pesticide alters the interactions between bumblebees and wild plants, was published Monday in Functional Ecology.

University of Guelph professor Nigel Raine, who also serves as the Rebanks Family Chair in pollination conservation, conducted the research with Dara Stanley from Royal Holloway University of London in the United Kingdom, who conducted the fieldwork for the study.

Bees

One finding from the study suggests when they come into contact with thiamethoxam – a neonic pesticide used in North America - bumblebees collected pollen on a more regular basis, but those not exposed to the pesticide collected pollen more efficiently.

Other findings include:

  • The pesticides can change how information travels through the bumblebee’s nervous system
  • Bumblebees with neonic exposure preferred different flowers over their counterparts without neonic exposure
  • Bumblebee foraging behaviour can change when exposed to “sublethal” levels of pesticide

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.